A feasible and more efficient SARS-Cov-2 vaccine allocation to states and counties in the USA
View ORCID ProfileAnthony R. Ives, View ORCID ProfileClaudio Bozzuto
doi: https://doi.org/10.1101/2021.03.17.21253793
Anthony R. Ives
1Department of Integrative Biology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Claudio Bozzuto
2Wildlife Analysis GmbH, Oetlisbergstrasse 38, 8053 Zurich, Switzerland.

Data Availability
All data used in this study are published and referenced in the main text.
Posted March 17, 2021.
A feasible and more efficient SARS-Cov-2 vaccine allocation to states and counties in the USA
Anthony R. Ives, Claudio Bozzuto
medRxiv 2021.03.17.21253793; doi: https://doi.org/10.1101/2021.03.17.21253793
Subject Area
Subject Areas
- Addiction Medicine (271)
- Allergy and Immunology (557)
- Anesthesia (135)
- Cardiovascular Medicine (1769)
- Dermatology (173)
- Emergency Medicine (316)
- Epidemiology (10812)
- Gastroenterology (594)
- Genetic and Genomic Medicine (2960)
- Geriatric Medicine (288)
- Health Economics (534)
- Health Informatics (1933)
- Health Policy (836)
- Hematology (293)
- HIV/AIDS (633)
- Medical Education (300)
- Medical Ethics (87)
- Nephrology (324)
- Neurology (2808)
- Nursing (152)
- Nutrition (433)
- Oncology (1473)
- Ophthalmology (444)
- Orthopedics (172)
- Otolaryngology (257)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (381)
- Pediatrics (868)
- Primary Care Research (338)
- Public and Global Health (5383)
- Radiology and Imaging (1016)
- Respiratory Medicine (727)
- Rheumatology (330)
- Sports Medicine (279)
- Surgery (327)
- Toxicology (48)
- Transplantation (150)
- Urology (126)